{
    "xml": "<topic id=\"PHP2936\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/lacosamide\" basename=\"lacosamide\" title=\"LACOSAMIDE\">\n<title>LACOSAMIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1129\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/lacosamide\">Lacosamide</xref>\n</p>\n<data name=\"vtmid\">441532003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_926692410\" title=\"Antiepileptics\">Antiepileptics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP62811\" outputclass=\"indicationsAndDose\" rev=\"1.27\" parent=\"/drugs/lacosamide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of focal seizures with or without secondary generalisation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 16&#8211;17 years</p>\n<p>Initially 50&#8239;mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50&#8239;mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 50&#8239;mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50&#8239;mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of focal seizures with or without secondary generalisation (alternative loading dose regimen when it is necessary to rapidly attain therapeutic plasma concentrations) (under close medical supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 16&#8211;17 years</p>\n<p>Loading dose 200&#8239;mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100&#8239;mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily), adjusted according to response, dose to be increased in weekly intervals.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Loading dose 200&#8239;mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100&#8239;mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily), adjusted according to response, dose to be increased in weekly intervals.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62971\" outputclass=\"contraindications\" rev=\"1.8\" parent=\"/drugs/lacosamide\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Second- or third-degree AV block</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63071\" outputclass=\"cautions\" rev=\"1.12\" parent=\"/drugs/lacosamide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Conduction problems</ph>; <ph outputclass=\"caution\">elderly</ph> (in adults); <ph outputclass=\"caution\">risk of PR-interval prolongation</ph>; <ph outputclass=\"caution\">severe cardiac disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62763\" outputclass=\"interactions\" rev=\"1.10\" parent=\"/drugs/lacosamide\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (lacosamide).</p>\n<p>Caution with concomitant use of drugs that prolong PR interval.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62607\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/lacosamide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abnormal gait</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">cognitive disorder</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">impaired coordination</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nystagmus</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Multi-organ hypersensitivity reaction</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Aggression</ph>; <ph outputclass=\"sideEffect\">agitation</ph>; <ph outputclass=\"sideEffect\">agranulocytosis</ph>; <ph outputclass=\"sideEffect\">atrial fibrillation</ph>; <ph outputclass=\"sideEffect\">atrial flutter</ph>; <ph outputclass=\"sideEffect\">AV block</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dysarthria</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">euphoria</ph>; <ph outputclass=\"sideEffect\">hypoesthesia</ph>; <ph outputclass=\"sideEffect\">irritability</ph>; <ph outputclass=\"sideEffect\">muscle spasm</ph>; <ph outputclass=\"sideEffect\">PR-interval prolongation</ph>; <ph outputclass=\"sideEffect\">psychosis</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">suicidal ideation</ph>; <ph outputclass=\"sideEffect\">tinnitus</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63119\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.24\" parent=\"/drugs/lacosamide\">\n<title>Allergy and cross-sensitivity</title>\n<body>\r\n\r\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\r\n<sectiondiv>\r\n<p>Antiepileptic hypersensitivity syndrome associated with lacosamide. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP63102\" outputclass=\"breastFeeding\" parent=\"/drugs/lacosamide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62867\" outputclass=\"hepaticImpairment\" parent=\"/drugs/lacosamide\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Titrate with caution in mild to moderate impairment if co-existing renal impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62648\" outputclass=\"renalImpairment\" parent=\"/drugs/lacosamide\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Loading dose regimen can be considered in mild to moderate impairment&#8212;titrate above 200&#8239;mg with caution.</p>\n<p>Titrate with caution in severe impairment, max. 250&#8239;mg daily.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Consult product literature for loading dose if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Consult product literature for loading dose if estimated glomerular filtration rate is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63145\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/lacosamide\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i>, give undiluted or dilute with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>For <i>intravenous infusion</i> (<i>Vimpat</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% <i>or</i> Sodium Chloride 0.9%. May be administered undiluted.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57684\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/lacosamide\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of syrup may include strawberry.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62701\" outputclass=\"patientAndCarerAdvice\" rev=\"1.14\" parent=\"/drugs/lacosamide\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Lacosamide for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures\">www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP62531\" outputclass=\"nationalFunding\" rev=\"1.12\" parent=\"/drugs/lacosamide\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (January 2009) that lacosamide (<i>Vimpat </i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland as adjunctive treatment for focal seizures with or without secondary generalisation in patients from 16 years. It is restricted for specialist use in refractory epilepsy.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2936-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/lacosamide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76392\" title=\"Tablet\" namespace=\"/drugs/lacosamide/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76397\" title=\"Oral solution\" namespace=\"/drugs/lacosamide/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76384\" title=\"Solution for infusion\" namespace=\"/drugs/lacosamide/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1129\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/lacosamide\" title=\"Lacosamide\" count=\"1\" rel=\"link\">Lacosamide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"1\" rel=\"link\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76392\" namespace=\"/drugs/lacosamide/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76397\" namespace=\"/drugs/lacosamide/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76384\" namespace=\"/drugs/lacosamide/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP2936",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/lacosamide",
    "basename": "lacosamide",
    "title": "LACOSAMIDE",
    "interactants": [
        {
            "id": "bnf_int_1129",
            "label": "Lacosamide"
        }
    ],
    "vtmid": "441532003",
    "drugClassification": [
        "Antiepileptics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of focal seizures with or without secondary generalisation",
                        "html": "Adjunctive treatment of focal seizures with or without secondary generalisation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth or intravenous infusion"
                    ],
                    "textContent": "By mouth or by intravenous infusion",
                    "html": "By mouth or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "Initially 50 mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50 mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100 mg twice daily (max. per dose 200 mg twice daily).",
                        "html": "<p>Initially 50&#8239;mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50&#8239;mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily).</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 50 mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50 mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100 mg twice daily (max. per dose 200 mg twice daily).",
                        "html": "<p>Initially 50&#8239;mg twice daily, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), then increased, if tolerated, in steps of 50&#8239;mg twice daily, adjusted according to response, dose to be increased in weekly intervals; maintenance 100&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of focal seizures with or without secondary generalisation (alternative loading dose regimen when it is necessary to rapidly attain therapeutic plasma concentrations) (under close medical supervision)",
                        "html": "Adjunctive treatment of focal seizures with or without secondary generalisation (alternative loading dose regimen when it is necessary to rapidly attain therapeutic plasma concentrations) (under close medical supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth or intravenous infusion"
                    ],
                    "textContent": "By mouth or by intravenous infusion",
                    "html": "By mouth or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "Loading dose 200 mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100 mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50 mg twice daily (max. per dose 200 mg twice daily), adjusted according to response, dose to be increased in weekly intervals.",
                        "html": "<p>Loading dose 200&#8239;mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100&#8239;mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily), adjusted according to response, dose to be increased in weekly intervals.</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Loading dose 200 mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100 mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50 mg twice daily (max. per dose 200 mg twice daily), adjusted according to response, dose to be increased in weekly intervals.",
                        "html": "<p>Loading dose 200&#8239;mg, infusion to be administered over 15&#8211;60 minutes (for up to 5 days), followed by maintenance 100&#8239;mg twice daily, to be given 12 hours after initial dose, then increased, if tolerated, in steps of 50&#8239;mg twice daily (max. per dose 200&#8239;mg twice daily), adjusted according to response, dose to be increased in weekly intervals.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Second- or third-degree AV block",
                "html": "Second- or third-degree AV block"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Conduction problems",
                "html": "Conduction problems"
            },
            {
                "type": "cautions",
                "textContent": "elderly in adults",
                "html": "elderly in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "risk of PR-interval prolongation",
                "html": "risk of PR-interval prolongation"
            },
            {
                "type": "cautions",
                "textContent": "severe cardiac disease",
                "html": "severe cardiac disease"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (lacosamide).\n\nCaution with concomitant use of drugs that prolong PR interval.",
                "html": "<p>Appendix 1 (lacosamide).</p><p>Caution with concomitant use of drugs that prolong PR interval.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abnormal gait",
                        "html": "Abnormal gait",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cognitive disorder",
                        "html": "cognitive disorder",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "impaired coordination",
                        "html": "impaired coordination",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nystagmus",
                        "html": "nystagmus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Multi-organ hypersensitivity reaction",
                        "html": "Multi-organ hypersensitivity reaction",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Aggression",
                        "html": "Aggression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "agitation",
                        "html": "agitation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "agranulocytosis",
                        "html": "agranulocytosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "atrial fibrillation",
                        "html": "atrial fibrillation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "atrial flutter",
                        "html": "atrial flutter",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "AV block",
                        "html": "AV block",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysarthria",
                        "html": "dysarthria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "euphoria",
                        "html": "euphoria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypoesthesia",
                        "html": "hypoesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "irritability",
                        "html": "irritability",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle spasm",
                        "html": "muscle spasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "PR-interval prolongation",
                        "html": "PR-interval prolongation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "psychosis",
                        "html": "psychosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "suicidal ideation",
                        "html": "suicidal ideation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tinnitus",
                        "html": "tinnitus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "references": [
                    {
                        "id": "PHP78230",
                        "label": "Epilepsy"
                    }
                ],
                "textContent": "Antiepileptic hypersensitivity syndrome associated with lacosamide. See under Epilepsy for more information.",
                "html": "<p>Antiepileptic hypersensitivity syndrome associated with lacosamide. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Titrate with caution in mild to moderate impairment if co-existing renal impairment.",
                "html": "<p>Titrate with caution in mild to moderate impairment if co-existing renal impairment.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in severe impairment&#8212;no information available.",
                "html": "<p>Caution in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Loading dose regimen can be considered in mild to moderate impairment&#8212;titrate above 200 mg with caution.\n\nTitrate with caution in severe impairment, max. 250 mg daily.",
                "html": "<p>Loading dose regimen can be considered in mild to moderate impairment&#8212;titrate above 200&#8239;mg with caution.</p><p>Titrate with caution in severe impairment, max. 250&#8239;mg daily.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Consult product literature for loading dose if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Consult product literature for loading dose if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Consult product literature for loading dose if estimated glomerular filtration rate is less than 30 mL/minute/1.73 m2.",
                "html": "<p>Consult product literature for loading dose if estimated glomerular filtration rate is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, give undiluted or dilute with Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i>, give undiluted or dilute with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "For intravenous infusion (Vimpat ), give intermittently in Glucose 5% or Sodium Chloride 0.9%. May be administered undiluted.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Vimpat</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% <i>or</i> Sodium Chloride 0.9%. May be administered undiluted.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of syrup may include strawberry.",
                "html": "<p>Flavours of syrup may include strawberry.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Lacosamide for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures\">www.medicinesforchildren.org.uk/lacosamide-for-preventing-seizures</xref>\n</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (January 2009) that lacosamide (Vimpat ) is accepted for restricted use within NHS Scotland as adjunctive treatment for focal seizures with or without secondary generalisation in patients from 16 years. It is restricted for specialist use in refractory epilepsy.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (January 2009) that lacosamide (<i>Vimpat </i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland as adjunctive treatment for focal seizures with or without secondary generalisation in patients from 16 years. It is restricted for specialist use in refractory epilepsy.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76392",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76397",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76384",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1129",
                "label": "Lacosamide",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76392",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76397",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76384",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}